Quick Takeaways:
- TARGAN has secured a $100M financing agreement with Symbiotic Capital, including an initial $30M tranche. The funding strengthens TARGAN’s balance sheet, replaces its previous lender Live Oak Bank, and supports its next phase of growth
- Proceeds will accelerate the global rollout of WingScan, TARGAN’s flagship platform, which is gaining traction across the US, Europe, and South America. The company is also investing in infrastructure and new product development to bring additional technologies to market in 2026-27
- Backed by strong commercial momentum, vwith revenue more than doubling from 2024 to 2025, TARGAN is expanding capacity and regional service networks. The company aims to advance data-driven, automated solutions that enhance efficiency, accuracy, and animal welfare across the poultry production value chain
Why It Matters?
The $100M Symbiotic Capital facility, with $30M already drawn, gives TARGAN flexible, non‑dilutive growth capital, resets its lender base, and underwrites faster global deployment of WingScan at a time when revenues are already more than doubling year on year.
By funding capacity, service infrastructure, and new product launches for 2026–27, TARGAN is positioned to entrench WingScan as a de facto standard in automated hatchery sexing while extending its data‑driven hardware‑plus‑software model into additional poultry workflows focused on efficiency, precision, and animal welfare.
Source: TARGAN
